by | Jun 27, 2024 | Publications
Tierarztl Prax Ausg K Kleintiere Heimtiere. 2024 Jun;52(3):167-173. doi: 10.1055/a-2324-0508. Epub 2024 Jun 26. ABSTRACT An acute, unilateral othematoma was diagnosed in a 9-year-old mixed-breed dog. There was no clinical or anamnestic evidence for the cause of the...
by | Jun 27, 2024 | Publications
Homeopathy. 2024 Jun 26. doi: 10.1055/s-0044-1786035. Online ahead of print. ABSTRACT BACKGROUND: Multiple myeloma (MM) is the second most common type of cancer among hematological malignancies and is difficult to treat. Although controversial in nature,...
by | Jun 27, 2024 | Publications
BMJ Case Rep. 2024 Jun 25;17(6):e258935. doi: 10.1136/bcr-2023-258935. ABSTRACT Multiple myeloma is a rare haematological malignancy characterised by the clonal proliferation of plasma cells within the bone marrow. Typical manifestations include bone pain, fatigue and...
by | Jun 26, 2024 | Publications
Int J Cancer. 2024 Jun 25. doi: 10.1002/ijc.35063. Online ahead of print. ABSTRACT At the end of 2022, a huge tide of SARS-CoV-2 infection mainly Omicron BA.4/5 developed in China. Multiple myeloma (MM) patients suffered cancer deterioration and mortality from...
by | Jun 26, 2024 | Publications
Cancer Med. 2024 Jun;13(12):e7372. doi: 10.1002/cam4.7372. ABSTRACT BACKGROUND: Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a potent treatment for relapsed or refractory multiple myeloma, demonstrating significant clinical efficacy. Despite these...
by | Jun 26, 2024 | Publications
J Cell Mol Med. 2024 Jun;28(12):e18504. doi: 10.1111/jcmm.18504. ABSTRACT Despite remarkable advancements in the treatment of multiple myeloma (MM), relapse remains a challenge. However, the mechanisms underlying this disease remain unclear. This study aimed to...
